NCT00177723View on ClinicalTrials.gov

Towards Reducing Resistance and Hematological Toxicity of Linezolid

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

February 28, 2007

Conditions
InfectionAdverse Effects
Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

Monash University

OTHER

lead

University of Pittsburgh

OTHER

NCT00177723 - Towards Reducing Resistance and Hematological Toxicity of Linezolid | Biotech Hunter | Biotech Hunter